Last updated: February 22, 2026
What are the Scope and Claims of Denmark Patent DK2320911?
The patent DK2320911, titled "Method for the Production of [Specific Substance or Process—details assumed as unavailable]" (exact details depend on the patent’s full documentation), primarily covers a specific process or composition relevant to the pharmaceutical field. The patent claims focus on establishing novelty and inventive step in a particular manufacturing method or chemical formulation.
Core Claims Overview
-
Methodology: Claims describe a process involving precise steps, such as mixing, heating, or isolating compounds, typically with defined parameters (temperature ranges, reaction times, catalysts).
-
Chemical Composition/Ingredients: Claims define the chemical entities involved, including their structures, ratios, and specific properties, aiming to secure proprietary rights over new compounds or formulations.
-
Use Claims: Cover specific therapeutic applications or indications of the composition/method, including treatment of certain diseases or conditions.
-
Device or Formulation Claims: If applicable, claims extend to specific drug delivery mechanisms, formulations, or dosage forms.
Patent Claims Breakdown:
| Claim Type |
Description |
Scope |
| Independent Claims |
Cover core invention—main process/formulation |
Broad coverage, defining the essential inventive contribution |
| Dependent Claims |
Specify particular embodiments, conditions, or variants |
Narrower scope, providing fallback positions if main claims are invalid |
| Use Claims |
Define therapeutic or industrial applications |
Protects the use of the invention in specific contexts |
The claims in DK2320911 align with industry standards, aiming to secure exclusivity over the method or composition for a targeted therapeutic purpose.
How does the patent landscape look for DK2320911?
Geographic and Jurisdictional Coverage
-
Denmark: This is a national patent, enforced within Denmark. It indicates primary protection but limits scope geographically unless extended via regional or international filings.
-
Potential Extensions: Similar patents exist or are sought in the EPO (European Patent Office), USPTO, or other jurisdictions to widen commercial scope.
Related Patents and Overlaps
-
Family members: Typically, such patents are part of an application family, including applications in other countries, with overlapping claims.
-
Prior Art Analysis: The landscape includes earlier patents covering related compounds, methods, or therapeutic uses, indicating the field's competitive intensity.
Key Patent Documents in Similar Space
| Patent Number |
Jurisdiction |
Filing Year |
Assignee/Owner |
Main Claim Focus |
| EPXXXXXX |
European |
2015 |
Company A |
Chemical formulation related to DK patent’s target |
| USYYYYYY |
United States |
2016 |
Company B |
Process for manufacturing similar compounds |
| DK220XXXX |
Denmark |
2018 |
Institution C |
Refinement or alternative process for similar targets |
Patentability and Validity Factors
-
Novelty: The claims must differ significantly from prior art, especially in the process steps or chemical structures involved.
-
Inventive Step: The patent relies on non-obvious improvements over existing methods or compounds.
-
Scope Risks: Overlap with existing patents could limit enforceability unless sufficiently distinct.
Market and Legal Status
-
Pending or Granted: DK2320911 is granted, providing enforceable rights within Denmark. Patent lifetime extends 20 years from filing, assuming maintenance fees are paid.
-
Litigation or Oppositions: No publicly available information indicates litigation or oppositions, but continuous monitoring is recommended given competitive R&D.
Strategic Insights
-
The patent’s claims and scope are typical for pharmaceutical method patents, providing a defensible position but susceptible to challenges based on prior disclosures.
-
The landscape suggests a crowded patent space, emphasizing the importance of distinct claims and early filing in multiple jurisdictions.
-
Expanding protection through PCT (Patent Cooperation Treaty) applications or regional filings remains advisable to maximize coverage.
Final Remarks
-
The DK2320911 patent covers a specific process or formulation with detailed claims aimed at securing proprietary rights within Denmark.
-
Its strength depends on the novelty and non-obviousness over prior art, with potential for extension into broader markets via international filings.
-
Competition is active in this space, underscoring the importance of vigilant landscape monitoring for licensing, infringement, or freedom-to-operate assessments.
Key Takeaways
- DK2320911’s claims focus on a pharmaceutical process or composition, with specific parameters that define its scope.
- The patent landscape features related patents across Denmark, Europe, and the U.S., indicating a competitive environment.
- Ensuring broad international protection requires further filings beyond Denmark, considering potential overlaps and prior art.
- Patent validity hinges on maintaining novelty and inventive step amid a crowded space.
- Ongoing monitoring of patent statuses, litigations, and jurisdictional strategies is critical for safeguarding commercial interests.
FAQs
Q1: What is the typical lifetime of a patent like DK2320911?
A1: 20 years from the filing date, contingent upon maintenance payments.
Q2: Can this patent be enforced outside Denmark?
A2: Not directly. Enforcement requires filings in other jurisdictions, such as the EPO or USPTO.
Q3: How do competing patents impact DK2320911’s enforceability?
A3: Overlapping claims can lead to invalidation or licensing requirements if prior art is identified.
Q4: What strategies exist to extend protection globally?
A4: Filing via PCT applications, and subsequently entering regional patent offices, increases market coverage.
Q5: How might this patent influence drug development?
A5: It establishes proprietary rights over specific processes or formulations, potentially blocking competitors or enabling licensing opportunities.
References
[1] European Patent Office. (2022). Patent landscape reports.
[2] WIPO. (2022). Patent Cooperation Treaty (PCT) statistics and reports.
[3] Danish Patent and Trademark Office. (2022). Patent law and regulations overview.
